
Jubilant's Spokane Facility Expands into Sterile Injectables and Radiopharma
The story in brief
Jubilant Pharmova's Spokane facility is expanding into a major US sterile-injectables platform, with growing PET radiopharma capacity and CRDMO operations showing operating leverage. Radiopharma, described as the company's most differentiated business, faces regulatory challenges but could drive margin recovery and incremental earnings with successful scaling. The $300 million expansion aims for 100 million vials of annual capacity by FY28.